Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT07703189
Active, not recruiting Observational

Taurodontism and Periodontal Status

NCT07703189 · tracked via the Priya Life Science Turkey tracker
Sponsor
Recep Tayyip Erdogan University Training and Research Hospital
Phase
Observational
Started
2026-07-08
Last updated
2026-07-14

Condition(s) studied

Taurodontism

Study summary

This retrospective cross-sectional observational study aims to evaluate the relationship between taurodontism and periodontal status. Clinical periodontal parameters and panoramic radiographs of systemically healthy adults will be retrospectively reviewed. Participants will be classified according to the presence or absence of taurodontism, and periodontal status will be assessed using clinical and radiographic findings. The study aims to determine whether taurodontism is associated with periodontal disease and periodontal health.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: Adults aged 18 to 65 years. Systemically healthy individuals. Availability of a diagnostic-quality panoramic radiograph. Presence of at least 20 natural teeth. No missing premolar or molar teeth. Availability of complete periodontal clinical records, including probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), plaque index (PI), and gingival index (GI). Exclusion Criteria: Poor-quality or nondiagnostic panoramic radiographs. Teeth with extensive caries or restorations that interfere with taurodontism assessment. Fractured teeth. Impacted teeth. Teeth with fused roots or an indistinguishable furcation area. Individuals with systemic diseases or conditions known to affect periodontal tissues. Incomplete clinical or radiographic records.

Primary outcome measure(s)

  • Periodontal status/ Probing Depth (PD) — Baseline
    Probing depth (PD) will be measured in millimeters at six sites per tooth using a periodontal probe and compared between participants with and without taurodontism.
  • Periodontal Status/ Clinical Attachment Level (CAL) — Baseline
    Clinical attachment level (CAL) will be measured in millimeters at six sites per tooth and compared between participants with and without taurodontism.
  • Periodontal Status/ Bleeding on Probing (BOP) — Baseline
    Bleeding on probing will be recorded as the presence or absence of bleeding after periodontal probing and compared between participants with and without taurodontism.
  • Periodontal status/ Plaque Index (PI) — Baseline
    Plaque Index (PI) will be assessed to evaluate oral hygiene status and compared between participants with and without taurodontism.
  • Periodontal Status/ Gingival Index (GI) — Baseline
    Gingival Index (GI) will be used to evaluate gingival inflammation and compared between participants with and without taurodontism.

Trial sites (1)

FacilityCityRegionStatus
Recep Tayyip Erdoğan University Merkez Rize Province

More Recep Tayyip Erdogan University Training and Research Hospital trials in Turkey

Salivary Stress Markers Associated With Malocclusion Severity Starting soon
Diagnostic Accuracy of ONSD, ODE, and the Crescent Sign Starting soon
Chronic Kidney Disease Associated Diet Starting soon
Different Local Anesthesia Techniques for Mandibular Primary Molar Pulpectomy Starting soon
Pathogenesis of Periodontal Disease in Individuals With Psoriasis Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07703189 on ClinicalTrials.gov ↗ ← All trials in Turkey